Core Viewpoint - Tong Ren Tang (600085.SH) has received approval from the Canadian Ministry of Health for product licenses for several of its products, indicating a significant step towards international market expansion [1] Group 1: Product Approval - Tong Ren Tang's subsidiary, Beijing Tong Ren Tang Pharmaceutical Factory, has obtained a Class III Product License for its products: Erganqing Oral Liquid, Suoyang Gujing Wan, Ren Shen Jianpi Wan, and Dahuang Zhechong Wan from the Canadian Ministry of Health [1] - The approval signifies that these products can be marketed in Canada, pending further compliance with Canadian regulations, including quality system certification for production sites [1] Group 2: Impact on Business - The recent approval is not expected to have a significant impact on the company's short-term operating performance [1]
同仁堂(600085.SH):多款产品获得加拿大产品许可证